Stockscreener 앱 받기
12.14
1.76%
0.21
시간 외 거래:
12.14
전일 마감가:
$11.93
열려 있는:
$11.96
하루 거래량:
97,911
Relative Volume:
0.34
시가총액:
$114.33M
수익:
-
순이익/손실:
$-81.17M
주가수익비율:
-1.1979
EPS:
-10.1344
순현금흐름:
$-82.84M
1주 성능:
+8.06%
1개월 성능:
+13.14%
6개월 성능:
-39.51%
1년 성능:
-54.45%
1일 변동 폭
$11.85
$12.46
1주일 범위
$10.90
$12.54
52주 변동 폭
$5.2044
$55.89
Korro Bio Inc Stock (KRRO) Company Profile
명칭
Korro Bio Inc
전화
617-468-1999
주소
60 FIRST STREET, CAMBRIDGE
Compare KRRO vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
12.14 | 112.35M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.05 | 123.82B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.28 | 81.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
816.95 | 52.00B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.36 | 44.14B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
352.23 | 40.83B | 4.98B | 69.60M | 525.67M | 0.5198 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-17 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2026-01-29 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2026-01-29 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2026-01-29 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2026-01-28 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2026-01-28 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-11-13 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-11-13 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2025-11-13 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-11-13 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-11-13 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-13 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2025-11-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-16 | 개시 | Chardan Capital Markets | Buy |
| 2025-01-10 | 개시 | Oppenheimer | Outperform |
| 2024-10-21 | 개시 | Raymond James | Strong Buy |
| 2024-08-14 | 개시 | William Blair | Outperform |
| 2024-03-28 | 재확인 | H.C. Wainwright | Buy |
| 2024-02-27 | 개시 | BMO Capital Markets | Outperform |
| 2023-12-04 | 개시 | H.C. Wainwright | Buy |
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-11-10 | 개시 | Piper Sandler | Overweight |
| 2023-02-15 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2021-09-22 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-01-27 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-12-22 | 개시 | B. Riley Securities | Buy |
| 2020-07-14 | 개시 | Oppenheimer | Outperform |
| 2020-05-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-10-28 | 개시 | Cowen | Outperform |
| 2019-10-28 | 개시 | Goldman | Buy |
| 2019-10-28 | 개시 | JP Morgan | Overweight |
모두보기
Korro Bio Inc 주식(KRRO)의 최신 뉴스
Korro Bio, Inc. CEO Ram Aiyar to Present at TD Cowen 46th Annual Health Care Conference - Quiver Quantitative
Korro to Present at the TD Cowen 46th Annual Health Care Conference - Bitget
RNA medicine developer Korro to present at three-day Boston health conference - Stock Titan
Trend Report: What is Origin Agritech Limiteds revenue forecast2025 Market Outlook & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Merger Talk: Is Korro Bio Inc exposed to political riskJuly 2025 Sentiment & Capital Efficient Trading Techniques - baoquankhu1.vn
Will Korro Bio Inc stock recover after earningsTrade Risk Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Can Korro Bio Inc. be recession proofQuarterly Trade Report & Long-Term Safe Return Strategies - mfd.ru
Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential - Investing.com South Africa
This Chewy Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
KRRO Receives Upgraded Analyst Rating and Price Target Boost fro - GuruFocus
KRRO Receives Upgraded Analyst Rating and Price Target Boost from Clear Street | KRRO Stock News - GuruFocus
Clear Street Upgrades Korro Bio (KRRO) - Nasdaq
William Blair Upgrades Korro Bio (KRRO) - Nasdaq
Korro Bio Shares Rise After William Blair Upgrade - marketscreener.com
Korro Bio (NASDAQ:KRRO) Upgraded to "Outperform" at William Blair - MarketBeat
Is Korro Bio Inc. stock a value trapJuly 2025 Levels & Low Risk Investment Opportunities - mfd.ru
Is Korro Bio Inc. stock a good dividend stockQuarterly Investment Review & AI Powered Buy and Sell Recommendations - mfd.ru
We Think Korro Bio (NASDAQ:KRRO) Needs To Drive Business Growth Carefully - Yahoo Finance
Can Korro Bio Inc. disrupt its industryMarket Growth Summary & Weekly Market Pulse Updates - mfd.ru
Korro Bio enhances executive compensation and retention incentives - MSN
Korro Bio, Inc. (NASDAQ:KRRO) Given Average Rating of "Hold" by Brokerages - MarketBeat
H.C. Wainwright Flag KRRO-121 as Independent Value Driver for Korro Bio, Inc. (KRRO) - MSN
Is FHN.PRB stock a good pick for beginnersJuly 2025 Analyst Calls & Precise Entry and Exit Recommendations - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Korro Bio (KRRO) and AstraZeneca (AZN) - The Globe and Mail
HC Wainwright Brokers Lower Earnings Estimates for Korro Bio - Defense World
Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength? - Nasdaq
Korro Bio Analyst Day: KRRO-121 RNA-Editing Candidate Targets Ammonia Control in UCD and HE - Yahoo Finance
Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential By Investing.com - Investing.com Nigeria
Korro Bio's KRRO-121 Receives Strong Analyst Upgrades - intellectia.ai
Korro Bio Shares Rise After Piper Sandler, HC Wainwright Upgrades - marketscreener.com
KRRO Shares Jump 13% On Analyst Upgrades — What’s Driving The Optimism? - Stocktwits
Korro Bio stock rating upgraded by H.C. Wainwright to Buy on new drug potential - Investing.com Canada
Piper Sandler Upgrades Korro Bio to Overweight From Neutral, Adjusts Price Target to $30 From $11 - marketscreener.com
HC Wainwright Upgrades Korro Bio to Buy From Neutral, Price Target is $20 - marketscreener.com
This Fortinet Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
HC Wainwright & Co. Upgrades Korro Bio (KRRO) - Nasdaq
KRRO Shares Jump 13% On Analyst UpgradesWhat's Driving The Optimism? - Mena FN
Piper Sandler upgrades Korro Bio stock rating to Overweight on UCD treatment - Investing.com Nigeria
Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential - Investing.com India
Oppenheimer Upgrades Korro Bio (KRRO) - Nasdaq
Korro Bio Shares Rise After Oppenheimer Upgrade - marketscreener.com
Raymond James reiterates Market Perform rating on Korro Bio stock By Investing.com - Investing.com India
Cantor Fitzgerald Upgrades Korro Bio to Overweight From Neutral - marketscreener.com
William Blair reiterates Market Perform rating on Korro Bio stock By Investing.com - Investing.com Canada
Korro Bio Inc (KRRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.52%
1.68%
자본화:
|
볼륨(24시간):